Table 6.
JAK2, CALR, and MPL mutational status in the 61 ET patients with thrombosis.
Mutation revealed in ET pts with thrombosis | # | % |
---|---|---|
JAK2 V617F | 49 | 80.4 |
CALR | 1 | 1.6 |
MPL | 1 | 1.6 |
Triple negativity | 10 | 16.4 |
Total | 61 | 100 |
JAK2, CALR, and MPL mutational status in the 61 ET patients with thrombosis.
Mutation revealed in ET pts with thrombosis | # | % |
---|---|---|
JAK2 V617F | 49 | 80.4 |
CALR | 1 | 1.6 |
MPL | 1 | 1.6 |
Triple negativity | 10 | 16.4 |
Total | 61 | 100 |